We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CHRN
11676
CALL
ChronoScale Holdings
CHRN
$3.04B
$63K ﹤0.01%
2,547
+1,634
+179% +$51.9K
GAIA icon
11677
PUT
Gaia
GAIA
$37.1M
$63K ﹤0.01%
14,900
-46,900
-76% -$228K
GTBP icon
11678
CALL
GT Biopharma
GTBP
$10.7M
$63K ﹤0.01%
707
-153
-18% -$11.6K
ORGO icon
11679
CALL
Organogenesis Holdings
ORGO
$230M
$63K ﹤0.01%
13,000
-15,600
-55% -$96K
PLG
11680
CALL
Platinum Group Metals
PLG
$189M
$63K ﹤0.01%
48,100
+20,200
+72% +$34.8K
SLNH icon
11681
PUT
Soluna Holdings
SLNH
$207M
$63K ﹤0.01%
616
-1,008
-62% -$196K
VCNX
11682
DELISTED
Vaccinex, Inc. Common Stock
VCNX
$63K ﹤0.01%
276
-47
-15% -$12K
QUOT
11683
CALL
DELISTED
Quotient Technology Inc
QUOT
$63K ﹤0.01%
21,200
-2,600
-11% -$12.3K
CVT
11684
CALL
DELISTED
Cvent Holding Corp. Common Stock
CVT
$63K ﹤0.01%
13,600
-2,300
-14% -$13.4K
ENDP
11685
PUT
DELISTED
Endo International plc
ENDP
$63K ﹤0.01%
134,900
-13,400
-9% -$17K
QIWI
11686
DELISTED
QIWI PLC
QIWI
$63K ﹤0.01%
30,713
-9,700
-24% -$19.9K
ARBK
11687
PUT
Argo Blockchain
ARBK
$42.1M
$62K ﹤0.01%
76
-61
-45% -$88.3K
CTRM icon
11688
PUT
Castor Maritime
CTRM
$22.6M
$62K ﹤0.01%
4,600
-17,960
-80% -$332K
EDTK icon
11689
Skillful Craftsman
EDTK
$14M
$62K ﹤0.01%
58,190
+12,398
+27% +$15.2K
FINV
11690
CALL
FinVolution Group
FINV
$1.03B
$62K ﹤0.01%
13,100
+100
+0.8% +$403
HOFV
11691
CALL
DELISTED
Hall of Fame Resort & Entertainment Co
HOFV
$62K ﹤0.01%
4,764
+2,696
+130% +$44.9K
VTSI icon
11692
VirTra
VTSI
$36.6M
$62K ﹤0.01%
12,649
-3,527
-22% -$18K
EGLX
11693
DELISTED
Enthusiast Gaming Holdings Inc. Common Stock
EGLX
$62K ﹤0.01%
31,031
+12,952
+72% +$28K
LFLY
11694
PUT
DELISTED
Leafly Holdings, Inc. Common Stock
LFLY
$62K ﹤0.01%
690
-3,215
-82% -$555K
USX
11695
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
$62K ﹤0.01%
23,144
+3,870
+20% +$12.1K
ML
11696
PUT
DELISTED
MoneyLion Inc.
ML
$62K ﹤0.01%
1,563
-520
-25% -$27.6K
ATCX
11697
CALL
DELISTED
Atlas Technical Consultants, Inc. Class A Common Stock
ATCX
$62K ﹤0.01%
11,800
-6,700
-36% -$63.4K
MUDSW
11698
DELISTED
Mudrick Capital Acquisition Corporation II Warrant
MUDSW
$62K ﹤0.01%
222,078
-277,922
-56% -$123K
NVIV
11699
DELISTED
InVivo Therapeutics Holdings Corp
NVIV
$62K ﹤0.01%
+15,127
New +$79.4K
ANY icon
11700
Sphere 3D
ANY
$18.1M
$61K ﹤0.01%
1,631
+966
+145% +$83.5K

Similar funds

Ken Griffin's Q2 2022 Portfolio in Review

As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.